Efficacy of rituximab in thymoma associated minimal change disease: case report.

El Ouafi Z, Mugnier C, Jeannet R, Danthu C, Duval M, Belle Mbou V, Touré F

Open source

DOI
10.1186/s12882-021-02479-8
Published
2021 Sep 7
Container
BMC nephrology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12882-021-02479-8,
  title = {Efficacy of rituximab in thymoma associated minimal change disease: case report.},
  author = {El Ouafi Z and Mugnier C and Jeannet R and Danthu C and Duval M and Belle Mbou V and Touré F},
  year = {2021},
  journal = {BMC nephrology},
  doi = {10.1186/s12882-021-02479-8},
  url = {https://doi.org/10.1186/s12882-021-02479-8}
}

RIS

TY  - JOUR
TI  - Efficacy of rituximab in thymoma associated minimal change disease: case report.
AU  - El Ouafi Z
AU  - Mugnier C
AU  - Jeannet R
AU  - Danthu C
AU  - Duval M
AU  - Belle Mbou V
AU  - Touré F
PY  - 2021
JO  - BMC nephrology
DO  - 10.1186/s12882-021-02479-8
UR  - https://doi.org/10.1186/s12882-021-02479-8
ER  - 

APA

Z, E. O., C, M., R, J., C, D., M, D., V, B. M., & F, T. (2021). Efficacy of rituximab in thymoma associated minimal change disease: case report.. BMC nephrology. https://doi.org/10.1186/s12882-021-02479-8

Source records